207 related articles for article (PubMed ID: 18952137)
41. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide.
Mei Z; Chen H; Weng T; Yang Y; Yang X
Eur J Pharm Biopharm; 2003 Sep; 56(2):189-96. PubMed ID: 12957632
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effect of triptolide on interleukin-18 and its receptor in rheumatoid arthritis synovial fibroblasts.
Lu Y; Wang WJ; Leng JH; Cheng LF; Feng L; Yao HP
Inflamm Res; 2008 Jun; 57(6):260-5. PubMed ID: 18516710
[TBL] [Abstract][Full Text] [Related]
43. Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-κB activation and acceleration of intrinsic myelin repair.
Sanadgol N; Golab F; Mostafaie A; Mehdizadeh M; Khalseh R; Mahmoudi M; Abdollahi M; Vakilzadeh G; Taghizadeh G; Sharifzadeh M
Toxicol Appl Pharmacol; 2018 Mar; 342():86-98. PubMed ID: 29407366
[TBL] [Abstract][Full Text] [Related]
44. [Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles].
Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
Yao Xue Xue Bao; 2004 Jul; 39(7):556-60. PubMed ID: 15493850
[TBL] [Abstract][Full Text] [Related]
45. Effects of cytochrome P4503A inducer dexamethasone on the metabolism and toxicity of triptolide in rat.
Ye X; Li W; Yan Y; Mao C; Cai R; Xu H; Yang X
Toxicol Lett; 2010 Feb; 192(2):212-20. PubMed ID: 19879934
[TBL] [Abstract][Full Text] [Related]
46. Caspase 3 is involved in the apoptosis induced by triptolide in HK-2 cells.
Shu B; Duan W; Yao J; Huang J; Jiang Z; Zhang L
Toxicol In Vitro; 2009 Jun; 23(4):598-602. PubMed ID: 19233258
[TBL] [Abstract][Full Text] [Related]
47. Triptolide inhibits the inflammatory activities of neutrophils to ameliorate chronic arthritis.
Huang G; Yuan K; Zhu Q; Zhang S; Lu Q; Zhu M; Sheng H; Yu R; Luo G; Xu A
Mol Immunol; 2018 Sep; 101():210-220. PubMed ID: 30007231
[TBL] [Abstract][Full Text] [Related]
48. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
Yang M; Gu Y; Yang D; Tang X; Liu J
J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753
[TBL] [Abstract][Full Text] [Related]
49. Triptolide loaded solid lipid nanoparticle hydrogel for topical application.
Mei Z; Wu Q; Hu S; Li X; Yang X
Drug Dev Ind Pharm; 2005 Jan; 31(2):161-8. PubMed ID: 15773283
[TBL] [Abstract][Full Text] [Related]
50. Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin.
Yuan ZX; Wu XJ; Mo J; Wang YL; Xu CQ; Lim LY
Eur J Pharm Biopharm; 2015 Aug; 94():363-71. PubMed ID: 26117184
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetic and pharmacodynamic study of triptolide-loaded liposome hydrogel patch under microneedles on rats with collagen-induced arthritis.
Chen G; Hao B; Ju D; Liu M; Zhao H; Du Z; Xia J
Acta Pharm Sin B; 2015 Nov; 5(6):569-76. PubMed ID: 26713272
[TBL] [Abstract][Full Text] [Related]
52. Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity.
Ren Q; Li M; Deng Y; Lu A; Lu J
Pharmacol Res; 2021 Mar; 165():105377. PubMed ID: 33484817
[TBL] [Abstract][Full Text] [Related]
53. Gender Differences in the Toxicokinetics of Triptolide after Single- and Multiple-dose Administration in Rats.
Liu L; Zhang J; Wang Z; Xu D; Jiang Z; Wang T; Ju W; Zhang L
Drug Res (Stuttg); 2015 Nov; 65(11):602-6. PubMed ID: 25647231
[TBL] [Abstract][Full Text] [Related]
54. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
[TBL] [Abstract][Full Text] [Related]
55. UPLC/ESI-QTOF-MS-based metabolomics survey on the toxicity of triptolide and detoxication of licorice.
Wang Z; Liu JQ; Xu JD; Zhu H; Kong M; Zhang GH; Duan SM; Li XY; Li GF; Liu LF; Li SL
Chin J Nat Med; 2017 Jun; 15(6):474-480. PubMed ID: 28629539
[TBL] [Abstract][Full Text] [Related]
56. Effect of poly(D, L-lactic acid) nanoparticles as triptolide carrier on abating rats renal toxicity by NMR-based metabolic analysis.
Liu M; Dong J; Yang Y; Yang X; Xu H
J Nanosci Nanotechnol; 2008 Jul; 8(7):3493-9. PubMed ID: 19051901
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice.
Kong LL; Zhuang XM; Yang HY; Yuan M; Xu L; Li H
Sci Rep; 2015 Jul; 5():11747. PubMed ID: 26134275
[TBL] [Abstract][Full Text] [Related]
58. Synergistically engineered nanotransethosomes for co-delivery of methotrexate and baicalin for enhanced transdermal delivery against rheumatoid arthritis: formulation, characterisation and in vivo pharmacodynamic evaluation.
Adin SN; Gupta I; Aqil M; Mujeeb M; Najmi AK
J Drug Target; 2024 Jul; 32(6):707-723. PubMed ID: 38652489
[No Abstract] [Full Text] [Related]
59. Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine.
Cui D; Hoshii Y; Kawano H; Sugiyama S; Gondo T; Liu Y; Ishihara T
Int Immunopharmacol; 2007 Sep; 7(9):1232-40. PubMed ID: 17630202
[TBL] [Abstract][Full Text] [Related]
60. Quercetin in w/o microemulsion: in vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo.
Vicentini FT; Simi TR; Del Ciampo JO; Wolga NO; Pitol DL; Iyomasa MM; Bentley MV; Fonseca MJ
Eur J Pharm Biopharm; 2008 Aug; 69(3):948-57. PubMed ID: 18304790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
